Assessment of right ventricular reserve utilizing exercise provocation in systemic sclerosis

[1]  W. Graninger,et al.  Exercise Pulmonary Resistances Predict Long-Term Survival in Systemic Sclerosis. , 2020, Chest.

[2]  Xiu-Zhang Lu,et al.  Influence of impaired right ventricular contractile reserve on exercise capacity in patients with precapillary pulmonary hypertension: A study with exercise stress echocardiography , 2019, Echocardiography.

[3]  D. Katritsis.  Abstracts of the Annual Spring Meeting 2017 of the European Congenital Heart Surgeons Association, Leicester, UK, 19-20th May, 2017 , 2017, Cardiology in the Young.

[4]  Paul G. Williams,et al.  Haemodynamic definitions and updated clinical classification of pulmonary hypertension , 2019, European Respiratory Journal.

[5]  E. Picano,et al.  Stressing the Cardiopulmonary Vascular System: The Role of Echocardiography. , 2018, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[6]  S. Plein,et al.  Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis , 2017, Rheumatology.

[7]  Ami A. Shah,et al.  (173) - Human Right Ventricular Myofilaments Exhibit Directionally Opposite Changes in Maximal Force and Calcium Sensitivity in Systemic Sclerosis-Associated versus Idiopathic Pulmonary Arterial Hypertension , 2017 .

[8]  Patrizio Lancellotti,et al.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, European heart journal cardiovascular Imaging.

[9]  Ami A. Shah,et al.  Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension , 2016, Circulation.

[10]  Ami A. Shah,et al.  Unique Abnormalities in Right Ventricular Longitudinal Strain in Systemic Sclerosis Patients , 2016, Circulation. Cardiovascular imaging.

[11]  Patrizio Lancellotti,et al.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[12]  Simon Gibbs,et al.  2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. , 2016, Revista espanola de cardiologia.

[13]  J. Voigt,et al.  Head-to-Head Comparison of Global Longitudinal Strain Measurements among Nine Different Vendors: The EACVI/ASE Inter-Vendor Comparison Study. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[14]  W. Kaltenborn,et al.  The Single-Breath Carbon Monoxide Diffusing Capacity , 2015 .

[15]  P. Pellikka,et al.  Reference Values for Right Ventricular Strain in Patients without Cardiopulmonary Disease: A Prospective Evaluation and Meta‐Analysis , 2015, Echocardiography.

[16]  R. Silver,et al.  Systemic sclerosis and the heart. , 2014, Rheumatic diseases clinics of North America.

[17]  J. Lumens,et al.  Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. , 2013, Journal of the American College of Cardiology.

[18]  M. Mayes,et al.  An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative , 2013 .

[19]  Ami A. Shah,et al.  Right Ventricular Dysfunction in Systemic Sclerosis–Associated Pulmonary Arterial Hypertension , 2013, Circulation. Heart failure.

[20]  H. Heinzl,et al.  Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study , 2013, Annals of the rheumatic diseases.

[21]  Jeroen J. Bax,et al.  Prognostic Value of Right Ventricular Longitudinal Peak Systolic Strain in Patients With Pulmonary Hypertension , 2012, Circulation. Cardiovascular imaging.

[22]  Ami A. Shah,et al.  Changes in estimated right ventricular systolic pressure predict mortality and pulmonary hypertension in a cohort of scleroderma patients , 2012, Annals of the rheumatic diseases.

[23]  James O. Mudd,et al.  Tricuspid Annular Plane Systolic Excursion Is a Robust Outcome Measure in Systemic Sclerosis-associated Pulmonary Arterial Hypertension , 2011, The Journal of Rheumatology.

[24]  V. Steen,et al.  Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): Baseline Characteristics and Description of Study Population , 2011, The Journal of Rheumatology.

[25]  T. Binder,et al.  Two dimensional speckle tracking echocardiography: clinical applications , 2010, Heart.

[26]  V. Bongard,et al.  New echocardiographic prognostic factors for mortality in pulmonary arterial hypertension. , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[27]  M. Humbert,et al.  Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcome. , 2010, Rheumatology.

[28]  Thomas Binder,et al.  Two dimensional speckle tracking echocardiography: basic principles , 2010, Heart.

[29]  P. Sengupta,et al.  Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[30]  P. Carreira,et al.  Comparison of baseline characteristics and survival between patients with idiopathic and connective tissue disease-related pulmonary arterial hypertension. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[31]  T. Abraham,et al.  Tricuspid annular displacement predicts survival in pulmonary hypertension. , 2006, American journal of respiratory and critical care medicine.

[32]  J. Krishnan,et al.  Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. , 2006, Arthritis and rheumatism.

[33]  M. Humbert,et al.  Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. , 2005, Arthritis and rheumatism.

[34]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[35]  Zvi Vered,et al.  Two-dimensional strain-a novel software for real-time quantitative echocardiographic assessment of myocardial function. , 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[36]  C. Appleton,et al.  A simple method for noninvasive estimation of pulmonary vascular resistance. , 2003, Journal of the American College of Cardiology.

[37]  G. Koch,et al.  Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. , 2002, Journal of the American College of Cardiology.

[38]  M. Costanzo,et al.  Asymmetry of right ventricular enlargement in response to tricuspid regurgitation. , 1999, Circulation.

[39]  M. Jetté,et al.  Metabolic equivalents (METS) in exercise testing, exercise prescription, and evaluation of functional capacity , 1990, Clinical cardiology.

[40]  T. Medsger,et al.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.

[41]  W. Kaltenborn,et al.  The single-breath carbon monoxide diffusing capacity. Reference equations derived from a healthy nonsmoking population and effects of hematocrit. , 1987, The American review of respiratory disease.

[42]  A. Van Tosh,et al.  Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. , 1985, Journal of the American College of Cardiology.

[43]  A. Masi.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[44]  James F. Fries,et al.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.

[45]  Julian F Thayer,et al.  Estimating cardiac output from blood pressure and heart rate: the liljestrand & zander formula. , 2015, Biomedical sciences instrumentation.

[46]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[47]  S. Solomon,et al.  GUIDELINES AND STANDARDS , 2010 .

[48]  Michael Becker,et al.  Myocardial strain measurement with 2-dimensional speckle-tracking echocardiography: definition of normal range. , 2009, JACC. Cardiovascular imaging.

[49]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.